Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-12-03 08:51:23
Victor Levitysky, Chief Scientific Officer of Targovax and primary insider,<br
/>
purchased on 2 December 2020 10,000 shares in Targovax ASA ("the Company") at
an<br />
average share price of NOK 10 per share. Following this transaction, Victor<br
/>
Levitsky holds 10,000 shares and 250,000 share options in the Company.<br />
<br />
***<br />
<br />
For further information, please contact:<br />
Renate Birkeli, Investor Relations<br />
Phone: +47 922 61 624<br />
Email: renate.birkeli@targovax.com<br />
Media enquires:<br />
Andreas Tinglum - Corporate Communications (Norway)<br />
Phone: +47 9300 1773<br />
Email: andreas.tinglum@corpcom.no<br />
<br />
IR enquires:<br />
Kim Sutton Golodetz - LHA Investor Relations (US)<br />
Email: kgolodetz@lhai.com<br />
Phone: +1 212-838-3777